Print

Devax, Inc. Initiates First Drug-Coated Stent Clinical Trial For A Dedicated Bifurcated Coronary Stent System 
10/19/2005 5:08:51 PM

Devax Inc. announced today the initiation of the AXXESS(TM) PLUS Clinical Study for the company's AXXESS Drug-Coated Stent System ("AXXESS Stent System"). The AXXESS Stent System is the first bifurcated stent design to elute an anti-restenonic drug. The AXXESS PLUS Clinical Study is a multi-center trial to evaluate both the acute and long-term clinical utility of the AXXESS Stent System for the treatment of bifurcated lesions in native coronary arteries.
//-->